Batingal, Andres C.
HRN: 29-21-08 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/22/2026
06/29/2026
IV
2.25 Gm
Q8h
CAP HR
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines